During the past decade, Chugoku Central Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chugoku Central Hospital" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Celgene" with 2 trials sponsored, "Daiichi Sankyo Co., Ltd." with 1 trials sponsored, "Loxo Oncology, Inc." with 1 trials sponsored and "MEI Pharma, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chugoku Central Hospital" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Kyowa Kirin, Inc." with 1 trials as a collaborator and "The Lymphoma Academic Research Organisation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Chugoku Central Hospital" are "Heart Failure" (2 trials), "Acute Myeloid Leukemia" (1 trials), "Follicular Lymphoma" (1 trials), "Follicular Lymphoma (FL)" (1 trials) and "Lymphoma, Mantle-Cell" (1 trials). Many other conditions were trialed in "Chugoku Central Hospital" in a lesser frequency.

Most popular intervention types in "Chugoku Central Hospital" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Rituximab" (3 trials), "Empagliflozin" (2 trials), "Lenalidomide" (2 trials) and "Acalabrutinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chugoku Central Hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Chugoku Central Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Chugoku Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chugoku Central Hospital, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".